Anoctamin 5 as a protective factor in prostate cancer: Insights from WGCNA, machine learning, and experimental analysis, with a focus on the anoctamin family.
Saved in:
| Title: | Anoctamin 5 as a protective factor in prostate cancer: Insights from WGCNA, machine learning, and experimental analysis, with a focus on the anoctamin family. |
|---|---|
| Authors: | Wang JS; Department of Urology, Yinfeng (Jinan) Hospital, Jinan, Shandong, 250014, China., Shao LL; Department of Oncology, Affiliated Tumor Hospital of Nantong University & Nantong Tumor Hospital, Nantong, Jiangsu, 226361, China., Yao D; Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University & Nantong Tumor Hospital. Nantong, Jiangsu, 226361, China., Sun DM; Department of Obstetrics and Gynecology, XuYi People's Hospital, Huaian, Jiangsu, 211700, China. Electronic address: 18852376166@139.com., Lan JJ; Internal Medicine, Community Health Service Center, Suzhou, Jiangsu, 215200, China. Electronic address: lanjianjun7373@163.com., Cong ZR; Department of Oncology, Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu, 226001, China. Electronic address: 13515211559@163.com. |
| Source: | Translational oncology [Transl Oncol] 2026 Jun; Vol. 68, pp. 102783. Date of Electronic Publication: 2026 Apr 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Neoplasia Press Country of Publication: United States NLM ID: 101472619 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1936-5233 (Print) Linking ISSN: 19365233 NLM ISO Abbreviation: Transl Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1936-5233 |
|---|---|
| DOI: | 10.1016/j.tranon.2026.102783 |
